News Author: Christopher Palmer Publish date: October 4, 2018
The tetracycline antibiotic was approved for CABP and acute bacterial skin and skin structure infections in adults.
News Author: Christopher Palmer Publish date: October 3, 2018
This is the first time a drug has been approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs.
News Author: Christopher Palmer Publish date: October 3, 2018
The new integrated analysis includes safety data from five clinical trials that were not included in the analysis from 2009.
News Author: Christopher Palmer Publish date: September 26, 2018
The shorter LOS with methadone vs. morphine could have relevance to clinical practice, given the increasing incid...
News Author: Christopher Palmer Publish date: September 24, 2018
There are many risk factors unique to teen drivers, but the AAP policy statement puts forward interventions to re...
News Author: Christopher Palmer Publish date: September 20, 2018
More culturally competent and appropriate interventions may be required.
News Author: Christopher Palmer Publish date: September 18, 2018
These microparticles are designed to work with laser therapy to improve responses to treatment.
News Author: Christopher Palmer Publish date: September 17, 2018
Previous analysis of CANTOS data showed canakinumab shortened the length of gout attacks.
News Author: Christopher Palmer Publish date: September 17, 2018
This is the first device approved for acute coronary artery perforations in 17 years.
News Author: Christopher Palmer Publish date: September 13, 2018
Enrollment for a phase 2 trial in HFpEF patients continues.
News Author: Christopher Palmer Publish date: September 13, 2018
The safety profile was fairly similar to that seen with intravenous formulations.
News Author: Christopher Palmer Publish date: September 13, 2018
Dr. Lawrence had been with ACOG for 11 years and been the EVP and CEO for 7 years.
News Author: Christopher Palmer Publish date: September 13, 2018
Although the correlation was high between CNS abnormalities and opthalmic abnormalities, there were exceptions.
News Author: Christopher Palmer Publish date: September 12, 2018
The substance is already outlawed in several countries and banned in some states.
News Author: Christopher Palmer Publish date: September 7, 2018
Rituximab plus lenalidomide had efficacy similar to that of rituximab plus chemotherapy in the treatment of follicular lymphoma (FL) in a phase 3 t...
